Clinical trials
Active, not recruiting Urinary Bladder Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 4 |
| Janssen Research & Development, LLC | 3 |
| AstraZeneca | 2 |
| BicycleTx Limited | 2 |
| UNICANCER | 2 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Eli Lilly and Company | 1 |
| IDEAYA Biosciences | 1 |
| Institut Bergonié | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 20 |
| Carcinoma, Transitional Cell | 3 |
| Neoplasm Metastasis | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Non-Muscle Invasive Bladder Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Urologic Neoplasms | 2 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.